Effects of quinine on neural activity in cat primary auditory cortex.
The effect of systemically applied quinine on single-unit firing activity in primary auditory cortex was investigated in seven cats. A dose of 100 or 200 mg/kg of quinine hydrochloride was administered intramuscularly and recordings from the same units were performed prior to application and continuously up to on average 5.5 h after administration. All animals showed 10-40 dB of threshold shift about 30 min after administration and some animals showed recovery during the course of the investigation. Significant increases were found in spontaneous firing rates for low-firing-rate units (initial firing rate < 1 spike/s). For high-firing-rate units (initial firing rate > 1 spike/s) no significant changes were observed. There were no significant changes in modal and mean interspike interval. The time-to-rebound peak in the autocorrelation function for spontaneous firings was not altered significantly. The rate of burst occurrence showed no significant change. The best modulation frequency in response to stimulation with periodic click trains decreased after administration, but the limiting rate did not change. Peak cross-correlation coefficients for the spontaneous firings of simultaneously recorded cells showed a significant increase and the correlogram's central peak was significantly narrower after quinine application. Dose effects were only present for cross-correlation results and temporal modulation transfer functions. The results for both spontaneous firing rate, peak width in the cross-correlogram and click stimulation were similar to those observed in salicylate-treated cats (Ochi and Eggermont, 1996). The other findings were different from those observed after salicylate. It is obvious that the effects of quinine on the auditory system are not the same as those of salicylate. The increased synchronization of the spontaneous firings across different neurons observed after application of both drugs may be related to tinnitus.
Ochi
K
K
Department of Psychology, University of Calgary, Alberta, Canada.
Eggermont
J J
JJ
D000161:Acoustic Stimulation; D000818:Animals; D001303:Auditory Cortex / Q000187:drug effects*; D001309:Auditory Threshold / Q000187:drug effects; D002415:Cats; D003344:Cortical Synchronization / Q000187:drug effects; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000633:toxicity; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects; D007273:Injections, Intramuscular; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000633:toxicity*; D009412:Nerve Fibers / Q000187:drug effects; D009474:Neurons / Q000166:cytology / Q000187:drug effects; D011803:Quinine / Q000008:administration & dosage / Q000633:toxicity*; D012459:Salicylates / Q000008:administration & dosage / Q000633:toxicity; D020156:Salicylic Acid; D014012:Tinnitus / Q000139:chemically induced / Q000209:etiology; D000159:Vestibulocochlear Nerve / Q000187:drug effects / Q000473:pathology
D004791:Enzyme Inhibitors; D009125:Muscle Relaxants, Central; D012459:Salicylates; D011803:Quinine; D020156:Salicylic Acid